Sunday 18 October 2026 Export VNDA’s income statement to Excel — free account

Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $216.1 million, up 8.72% from fiscal 2024. In the quarter to June 2026, revenue fell 3.92%, EPS fell 126.1%, free cash flow fell 101.0% and total debt rose 2.98%, each against the same quarter a year earlier.

4.03 0.21 −4.95%

Follow VNDA

Alert me

Market cap: $256.4M
P/E: 0.0×
Fwd P/E: −2.6×
Dividend yield: —
F-score: 2/9
Altman Z: 0.72
Beneish M: −3.88
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		1.39	2.41	1.89	1.71
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(9.32)	(17.67)	(8.18)	(11.86)
P/B ratio Full definition →		0.63	1.59	1.46	1.67
Price to Tangible BV Full definition →		0.83	2.47	2.48	3.44
EV/Sales Full definition →		0.02	1.20	0.98	0.94
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		(0.05)	(2.38)	(1.68)	(1.42)
EV/FCF Full definition →		(0.05)	(2.35)	(1.55)	(1.32)
Quick Ratio Full definition →		2.92	2.19	1.91	1.40
Current Ratio Full definition →		3.12	2.39	2.16	1.61
Net Debt/EBITDA Full definition →		9.25	7.48	4.24	2.77
Debt/Assets Full definition →		0.47%	0.83%	0.87%	0.77%
Debt/Equity Full definition →		0.01	0.01	0.01	0.01
Asset Turnover Full definition →		0.34	0.38	0.41	0.42
Operating CF/Net income Full definition →		1.40	0.21	1.03	0.50
Capex/Depreciation Full definition →		1.02	(0.02)	(3.01)	(0.05)
Research and Development Expense of Revenue Full definition →		40.11%	50.70%	54.98%	73.13%
Selling, General and Administrative Expense of Revenue Full definition →		107.14%	110.07%	132.18%	142.17%
Intangible Assets out of Total Assets Full definition →		0.18	0.24	0.27	0.27
Share Based Compensation of Revenue Full definition →		3.75%	3.99%	4.96%	4.17%
Graham Net Nets Full definition →		0.79	0.36	0.34	0.20
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(28.46%)	(42.29%)	(58.61%)	(75.65%)
Free Cash Flow Yield Full definition →		(28.13%)	(21.25%)	(33.42%)	(41.51%)
Revenue per Share Full definition →		0.95	0.97	0.87	0.84
Operating CF per Share Full definition →		(0.54)	(0.50)	(0.84)	(0.52)
Capex per Share Full definition →		0.00	0.00	(0.17)	0.00
Free Cash Flow per Share Full definition →		(0.54)	(0.50)	(1.02)	(0.52)
Cash per Share Full definition →		4.97	4.48	3.40	2.82
Shareholders Equity per Share Full definition →		7.89	5.55	4.72	3.66
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		7.89	5.55	4.72	3.66
Free Cash Flow Full definition →		(31.79)	(29.52)	(60.44)	(31.26)
Working Capital Full definition →		249.63	202.10	157.59	100.46
Capital Expenditures Full definition →		(0.16)	(0.10)	(10.22)	(0.19)
Net Current Asset Value Full definition →		232.36	185.50	140.41	72.20
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.20	0.00
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		46.65	50.84	50.74	52.34
Average Payables Full definition →		43.46	53.69	52.95	63.56
Average Inventory Full definition →		1.83	1.79	1.81	1.92
Average Assets Full definition →		623.13	572.58	532.73	518.61
Average Common Equity Full definition →		503.61	432.87	396.09	353.26

Show all line items

Columns are period end dates

Stockrow Weekly